Newsletter | March 28, 2025

03.28.25 -- The Future Of GLP-1 Analogues: Key Tech, Supply-Chain Insights, And Strategies

FEATURED EDITORIAL

The Technologies Propelling GLP-1 Analogues

Explore various manufacturing and synthesis technologies for GLP-1 drugs, along with innovative drug delivery systems and advanced techniques being utilized in their development.

Supply-Chain Statistics And Realistic Outsourcing Options

Kishore Hotha, President, Dr. Hotha’s Life Sciences, provides some telling stats that should inform outsourcing decision-making in the coming months… and perhaps years.

One Percent Of A Hundred People's Efforts

Persephoni BioPartners CEO Hilary Shultz, and newly hired Chief Scientific Officer William Heath – a 34-year veteran of Eli Lilly – explain their biotech-forming business model, dubbed a venture studio, and provide sound advice on working with CDMOs.

INDUSTRY INSIGHTS

Control API Impurities To Achieve Therapeutic Safety And Efficacy For Patients

In your CDMO search, prioritize finding a partner who recognizes impurity control as a critical component of patient-focused drug development and offers the necessary capabilities to ensure it.

Third Principle Of Green Chemistry: Less Hazardous Chemical Syntheses

Chemists and engineers must prioritize sustainable practices by innovating processes that minimize environmental impact and toxicity, addressing challenges like solvent waste and molecule synthesis.

Optimizing Punch Force Ratings: Adjusting For Bending, Buckling

When manufacturing mini-tablets, adjusting punch force ratings is crucial to prevent bending or buckling. The Rankine-Gordon formula offers a safer force rating for microtip tooling.

The Power Of AI And Route Scouting To Navigate API Complexity

Using AI tools for retrosynthesis can help you investigate molecules interactively to build a complex API manufacturing process that maintains your timeline and saves you money.

Critical Considerations for the Manufacturing of Highly Potent Drugs

Examine the intricacies of manufacturing highly potent APIs and associated drug products to ensure compliance with GMP regulations.

SOLUTIONS

Cambrex Scientist Spotlight: Shawn Conway

Shawn Conway, Senior Director of Operations in High Point, NC, leads a dynamic team of engineers and chemists at Cambrex, focused on supporting clients throughout the entire product life cycle.

A Leading CDMO Ready To Meet Your Complex Oral Solid Dose Needs

By leveraging Pfizer’s global expertise and in-depth understanding of the complexity involved in OSD manufacturing, we help identify solutions quickly if and when issues arise.

Solid Form Services

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

Capacity Update January 2025: Small Molecule

Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with R&D and QC laboratories.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: